<DOC>
	<DOCNO>NCT02063412</DOCNO>
	<brief_summary>The objective study compare possible time saving reduction nurse pharmacy time manage AEGC patient use capecitabine-based regimen versus traditional intravenous chemotherapy Hong Kong public hospital setting .</brief_summary>
	<brief_title>Nursing Pharmacy Care Between Capecitabine 5-Fluoruracil Regimens</brief_title>
	<detailed_description>Advanced esophageal gastric cancer ( AEGC ) rank top 10 cancer-related cause death worldwide , approximately one million new case year . Over half new case East Asia . The traditional chemotherapy AEGC remain intravenous ( IV ) fluorouracil ( 5-FU ) , cisplatin , anthracyclines . Trials favour combined use 5-FU cisplatin superior efficacy quality life AEGC patient . Recent year , oral chemotherapy practical economic advantage IV regimen . It understandable patient prefer oral regimen long clinical efficacy maintain . Oral treatment strategy preserve quality life AEGC patient . In addition , may also additional cost save nurse pharmacy time . It significant amount time save nursing pharmacy preparation administration IV chemotherapy However , lack local data demonstrate impact pharmacy nurse care utilize capecitabine-based regimen compare traditional IV chemotherapy MCRC patient Hong Kong .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . Aged 18 2 . Diagnosed AEGC prescribe either XELOXbased FOLFOX4 base chemotherapy treatment 1 . Persons &lt; 18 year age ; 2 . Pregnant lactating woman ; 3 . Persons relate unequally investigator ( e.g . student , employee ) ; 4 . Special population ( e.g . prisoner , mentally , congnitively disabled ) ; 5 . Patients refuse sign consent willing participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>